Replimune Group, Inc. (REPL)
NASDAQ: REPL · Real-Time Price · USD
9.59
+0.25 (2.68%)
Jul 9, 2025, 9:50 AM - Market open
Replimune Group Market Cap
Replimune Group has a market cap or net worth of $739.26 million as of July 9, 2025. Its market cap has increased by 52.95% in one year.
Market Cap
739.26M
Enterprise Value
312.35M
1-Year Change
52.95%
Ranking
Category
Stock Price
$9.59
Market Cap Chart
Since July 20, 2018, Replimune Group's market cap has increased from $467.51M to $739.26M, an increase of 58.13%. That is a compound annual growth rate of 6.79%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 700.84B |
| Johnson & Johnson | 375.37B |
| AbbVie | 334.34B |
| Novo Nordisk | 316.33B |
| UnitedHealth Group | 279.90B |
| Novartis AG | 242.35B |
| Abbott Laboratories | 233.90B |
| AstraZeneca | 218.65B |